Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?

Understanding the implications of cardiovascular (CV) outcomes data of glucose-lowering agents on the management of type 2 diabetes mellitus can be challenging for many primary practitioners. Amongst different classes of diabetes medications assessed for CV safety, several agents within the sodium-g...

Descripción completa

Detalles Bibliográficos
Autores principales: Deed, Gary, Atherton, John J., d’Emden, Michael, Rasalam, Roy, Sharma, Anita, Sindone, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778570/
https://www.ncbi.nlm.nih.gov/pubmed/31292928
http://dx.doi.org/10.1007/s13300-019-0663-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778570/
https://www.ncbi.nlm.nih.gov/pubmed/31292928
http://dx.doi.org/10.1007/s13300-019-0663-x

Ejemplares similares